Tong Chen, MD, PhD
College of Medicine
Molecular Carcinogenesis and Chemoprevention
Cancer, Carcinoma, Squamous Cell, Esophageal Cancer, Mouth Cancer, Anoxia, Papilloma, DNA Damage
As a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, Tong Chen, MD, PhD, investigates the mechanisms through which natural food products prevent esophageal cancer.Among her recent collaborative projects is a study that produced evidence to suggest that T315 is a novel class of anticancer drug able to inhibit growth of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-resistant lung adenocarcinoma cells by inducing degradation of EGFR. Dr. Chen has co-authored many articles in well-respected publications, including Leukemia Research, American Journal of Respiratory and Critical Care Medicine, Oncotarget and Nutrients.